SCHEMBL1496563

SCHEMBL1496563

CC(=O)Nc1ccc(NCC(C)C)c(N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
HDAC1 Q13547 6/20 0.47
HDAC3 O15379 1/20 0.46
HDAC2 Q92769 1/20 0.46
NCOR2 Q9Y618 1/20 0.46
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 2/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.43
MAPT P10636 2/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
MAOA P21397 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
IDO1 P14902 1/20 0.41
HTT P42858 2/20 0.40
RORC P51449 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3070660 0.83 HTT (0.58) TDP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL3440911 0.82 PRKCI (0.61) ALDH1A1HSD17B10MAPTNPC1RAB9A
SCHEMBL11027199 0.81 HDAC1 (0.60) TDP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL1496520 0.80 MEN1 (0.54) HDAC1HDAC3HDAC2NCOR2ALDH1A1
SCHEMBL1496463 0.78 HTT (0.67) TDP1ALDH1A1PKMMAPK1MAPT
SCHEMBL8352164 0.77 HSD17B10 (0.55) TDP1ALDH1A1HSD17B10PKMMAPK1
SCHEMBL5881733 0.77 PTGER4 (0.56) TDP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL10763967 0.75 RAB9A (0.58) ALDH1A1HSD17B10MAPTMEN1RAB9A
SCHEMBL7811924 0.75 HTT (0.56) TDP1ALDH1A1MAPK1MAPTMEN1
SCHEMBL7970378 0.75 TDP1 (0.46) TDP1HDAC1HDAC3HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011023722-A1 NOVEL QUINOXALINONE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-03 WO disclosed